# Magnetic Resonance Guided High Intensity Focused Ultrasound in Advanced Pancreatic Adenocarcinoma Treatment

> **NCT04298242** · NA · COMPLETED · sponsor: **Stanford University** · enrollment: 1 (actual)

## Conditions studied

- Pancreatic Adenocarcinoma

## Interventions

- **DEVICE:** ExAblate 2100

## Key facts

- **NCT ID:** NCT04298242
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-22
- **Primary completion:** 2021-06-15
- **Final completion:** 2021-06-15
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2023-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04298242

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04298242, "Magnetic Resonance Guided High Intensity Focused Ultrasound in Advanced Pancreatic Adenocarcinoma Treatment". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT04298242. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*